Stigma and Substance Use Disorders

STIGMA AND SUDS

Definition of Stigma

Stigma refers to a form of discrimination directed against an identifiable group of people, a place, or a nation. Stigma associated with individuals suffering from substance use disorders (SUD) often involves inaccurate and unfounded perceptions, such as:

  • Individuals with SUD are dangerous.

  • They are incapable of managing their treatment effectively.

  • They are personally at fault for their condition.

Origins of Stigma

The stigma surrounding individuals with SUD can be traced back to outdated and incorrect beliefs that addiction is a moral failing. However, contemporary understanding classifies addiction as a chronic and treatable disease, from which patients can recover and lead healthy lives.

Impact of Stigma on Individuals with SUD

Experiencing stigma can significantly hinder individuals with SUD from seeking necessary treatment. Evidence suggests that prevalent stigmatizing attitudes can elicit feelings of pity, fear, and anger in others, prompting a desire for social distance from those affected by SUD. Moreover, such stigmatizing language may negatively affect the perceptions of healthcare providers regarding these individuals, thereby influencing the quality of care delivered to them.

CONSIDERATIONS TO KEEP IN MIND

Communication Approaches

When interacting with individuals affected by SUD, their families, and colleagues, it is critical to employ non-stigmatizing language that reflects a scientific understanding of SUD, consistent with the role of a healthcare professional. Since clinicians often serve as initial contact points for individuals with SUD, they must take proactive steps to minimize stigma and associated biases. This involves becoming educated on terms that should be avoided and those that should be used.

Person-First Language

Utilizing person-first language is essential, allowing individuals to dictate their preferred terms of identification. Person-first language preserves the dignity of individuals by refraining from equating them with their condition or employing terms that carry negative connotations. For instance, rather than labeling someone as an "addict," it is more appropriate to use terminology such as “person with a substance use disorder,” which maintains a neutral tone and separates the person from their diagnosis.

Recommended Terminology

It is advisable to employ the term “substance use” for all substances, including alcohol and other drugs, and to use severity specifiers (e.g., mild, moderate, severe) to articulate the extent of the SUD. This precise language facilitates accurate clinical assessment and the development of effective treatment strategies. Additionally, when discussing treatment plans with affected individuals and their families, evidence-based language should be prioritized over terms that characterize treatment as a mere intervention.

FOUNDATIONS OF ADDICTION

Neurobiology

Understanding the neurobiological mechanisms underpinning substance use disorders is crucial to grasp the complexities of addiction and its treatment.

Historical Context

The historical development of substance use, treatment and societal perceptions play a significant role in contemporary addiction understanding and management.

NEUROBIOLOGY OF SUBSTANCE USE DISORDERS

Overview of the Neurobiology of SUDs

Chronic substance use leads to both structural and functional brain abnormalities which perpetuate dependency as a means to avoid withdrawal symptoms. These brain changes are often exacerbated by environmental factors such as:

  • Stress.

  • The social context surrounding initial substance use.

  • Classical conditioning experiences tied to substance exposure.
    Additionally, genetic components may play a role, predisposing certain individuals to develop substance use disorders through abnormal brain pathways.

Neuroanatomy of Reward Systems

The natural reward systems of the brain, which include vital elements such as food, water, sex, and nurturing experiences, enhance behaviors necessary for survival by eliciting pleasure. The pathways responsible for these rewards also harness motivation for repetition of such behaviors.

Reward Pathway Components

Key regions in the brain involved in reward processing include:

  • Ventral Tegmental Area (VTA): Connected to both the nucleus accumbens and the prefrontal cortex, this area transmits dopamine through its dopaminergic neurons.

  • Nucleus Accumbens (NA): Plays a central role in mediating reward-related activities, facilitating positive valence experiences.

  • Prefrontal Cortex (PFC): It is engaged in decision-making processes and forecasting rewarding experiences by attributing salience to environmental stimuli and modulating the intensity of behavioral responses.

Integration of Brain Responses

Adaptive behaviors are mediated by these three brain areas, consolidating motivational and affective states with external stimuli, ultimately predicting rewards and dictating responses necessary for acquiring natural rewards.

DRUG TOLERANCE AND WITHDRAWAL

Tolerance

Tolerance is characterized by the necessity to elevate drug dosage to achieve prior effects. This phenomenon occurs due to the brain’s receptors becoming progressively less sensitive to the stimulus of external substances.

Withdrawal

Withdrawal syndrome manifests as a consequence of abruptly stopping the intake of a substance, leading to disruptions in the central nervous system (CNS). This condition encompasses the activation of the thalamus, the release of corticotropin-releasing factor (CRF), and activation of the locus coeruleus (LC).

Neurotransmitters Involved in Withdrawal

Several neurotransmitters play pivotal roles during withdrawal:

  • Dopamine: Associated with feelings of dysphoria.

  • Serotonin: Also contributes to dysphoria.

  • Opioid Peptides: Can increase sensations of pain.

  • GABA: Is linked with anxiety and panic attacks.

  • Dynorphin: Associated with feelings of dysphoria.

  • Corticotropin-Releasing Factor (CRF): Tied to stress responses.

  • Norepinephrine (NE): Contributes to stress.

  • Glutamate: Can cause hyperexcitability.

Patients undergoing withdrawal often report experiences of dysphoria, irritability, depression, and anger.

PROGRESSION TO SUBSTANCE USE DISORDER

Initial experiences of pleasure from drug use arise through the brain’s natural reward system, establishing the first stage of SUD. This limited or occasional use can evolve into daily and compulsive drug consumption. Repeated, uncontrolled exposure to drugs leads to a chronic state of drug intake, accompanied by neuroplastic adjustments at each developmental stage of SUD, reinforcing connections across specific brain areas.

MODELS OF SUBSTANCE USE

Key models addressing substance use include:

  • Changed Set Point Model: Suggests that drug use alters an individual's biological or physiological baseline.

  • Cognitive Deficits Model: Posits that individuals who develop SUDs frequently display abnormalities within the prefrontal cortex, which are observable among chronic drug users.

  • Stress Model: Notes that individuals with SUD are often more susceptible to stress.